• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

赤道几内亚比奥科岛恶性疟原虫分离株中pfmdr1基因N86Y和Y184F突变的高流行率。

High prevalence of pfmdr1 N86Y and Y184F mutations in Plasmodium falciparum isolates from Bioko Island, Equatorial Guinea.

作者信息

Li Jian, Chen Jiangtao, Xie Dongde, Monte-Nguba Santiago-M, Eyi Juan Urbano Monsuy, Matesa Rocio Apicante, Obono Maximo Miko Ondo, Ehapo Carlos Sala, Yang Liye, Lu Danjie, Yang Hui, Yang Hui-Tian, Lin Min

出版信息

Pathog Glob Health. 2014 Oct;108(7):339-43. doi: 10.1179/2047773214Y.0000000158. Epub 2014 Oct 27.

DOI:10.1179/2047773214Y.0000000158
PMID:25348116
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4241786/
Abstract

OBJECTIVE

Drug resistance against Plasmodium falciparum has been recognized as the crucial obstacle to curbing mortality and morbidity from malaria. To investigate the distribution and pattern of multidrug resistance 1 (pfmdr1) gene polymorphisms in P. falciparum, isolates collected from the malaria high-endemic Bioko Island, Equatorial Guinea.

METHODS

Blood samples were collected from 217 patients with P. falciparum malaria during rainy season in 2012 on Bioko Island. These samples were extracted using Chelex to obtain parasite DNA. Nest-polymerase chain reaction (PCR) and sequencing were employed to detect mutations (N86Y, E130K, Y184F, S1034C, N1042D, V1109I, and D1246Y) and haplotypes in pfmdr1 gene.

RESULTS

A total of 151 samples were successfully detected for pfmdr1 mutations from the 217 patients. Pfmdr1 mutations were found in 91·39% (138/151) P. falciparum isolates. However, no mutation at 130 and 1109 was identified from these samples. Four haplotypes coding 86, 184, 1034, 1,042, and 1,246 were found including NYSND, YYSND, NFSND, and YFSND, which accounted for 8·61% (13/151), 2·65% (4/151), 29·80% (45/151), and 58·94% (89/151), respectively.

CONCLUSIONS

Our results exhibited hypersensitivity to lumefantrine (LU) and mefloquine (MQ) and resistance to chloroquine (CQ) and amodiaquine (AQ) in P. falciparum isolates from Bioko Island. This information will be useful for anti-malarial drug policy in Equatorial Guinea.

摘要

目的

恶性疟原虫耐药性已被视为遏制疟疾死亡率和发病率的关键障碍。为调查赤道几内亚疟疾高流行的比奥科岛恶性疟原虫多药耐药1(pfmdr1)基因多态性的分布及模式,收集了疟原虫分离株。

方法

2012年雨季期间,在比奥科岛从217例恶性疟患者采集血样。使用螯合树脂提取这些样本以获得疟原虫DNA。采用巢式聚合酶链反应(PCR)和测序检测pfmdr1基因中的突变(N86Y、E130K、Y184F、S1034C、N1042D、V1109I和D1246Y)及单倍型。

结果

在217例患者中,共成功检测到151份样本存在pfmdr1突变。在91.39%(138/151)的恶性疟原虫分离株中发现了pfmdr1突变。然而,在这些样本中未鉴定出130和1109位点的突变。发现了编码86、184、1034、1042和1246位点的四种单倍型,分别为NYSND、YYSND、NFSND和YFSND,占比分别为8.61%(13/151)、2.65%(4/151)、29.80%(45/151)和58.94%(89/151)。

结论

我们的结果显示,比奥科岛恶性疟原虫分离株对本芴醇(LU)和甲氟喹(MQ)敏感,对氯喹(CQ)和阿莫地喹(AQ)耐药。该信息将有助于赤道几内亚制定抗疟药物政策。

相似文献

1
High prevalence of pfmdr1 N86Y and Y184F mutations in Plasmodium falciparum isolates from Bioko Island, Equatorial Guinea.赤道几内亚比奥科岛恶性疟原虫分离株中pfmdr1基因N86Y和Y184F突变的高流行率。
Pathog Glob Health. 2014 Oct;108(7):339-43. doi: 10.1179/2047773214Y.0000000158. Epub 2014 Oct 27.
2
Molecular mutation profile of Pfcrt and Pfmdr1 in Plasmodium falciparum isolates from Bioko Island, Equatorial Guinea.赤道几内亚比奥科岛恶性疟原虫分离株中Pfcrt和Pfmdr1的分子突变谱
Infect Genet Evol. 2015 Dec;36:552-556. doi: 10.1016/j.meegid.2015.08.039. Epub 2015 Aug 29.
3
Return of chloroquine-sensitive Plasmodium falciparum parasites and emergence of chloroquine-resistant Plasmodium vivax in Ethiopia.埃塞俄比亚出现对氯喹敏感的恶性疟原虫寄生虫以及对氯喹耐药的间日疟原虫。
Malar J. 2014 Jun 25;13:244. doi: 10.1186/1475-2875-13-244.
4
A comprehensive survey of polymorphisms conferring anti-malarial resistance in Plasmodium falciparum across Pakistan.巴基斯坦恶性疟原虫抗疟耐药性相关多态性的全面调查。
Malar J. 2013 Aug 29;12:300. doi: 10.1186/1475-2875-12-300.
5
Prevalence of crt and mdr-1 mutations in Plasmodium falciparum isolates from Grande Comore island after withdrawal of chloroquine.氯喹停用后大科摩罗岛恶性疟原虫分离株中crt和mdr-1突变的流行情况
Malar J. 2016 Aug 15;15(1):414. doi: 10.1186/s12936-016-1474-4.
6
Role of Pfmdr1 in in vitro Plasmodium falciparum susceptibility to chloroquine, quinine, monodesethylamodiaquine, mefloquine, lumefantrine, and dihydroartemisinin.Pfmdr1在恶性疟原虫对氯喹、奎宁、单去乙基氨喹啉、甲氟喹、本芴醇和双氢青蒿素的体外易感性中的作用。
Antimicrob Agents Chemother. 2014 Dec;58(12):7032-40. doi: 10.1128/AAC.03494-14. Epub 2014 Sep 8.
7
[Drug-resistant gene polymorphisms in isolated from Bioko Island, Equatorial Guinea in 2018 and 2019].2018年和2019年从赤道几内亚比奥科岛分离出的耐药基因多态性
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi. 2021 Aug 19;33(4):396-400. doi: 10.16250/j.32.1374.2021128.
8
Survey of Plasmodium falciparum multidrug resistance-1 and chloroquine resistance transporter alleles in Haiti.海地恶性疟原虫多药耐药-1 和氯喹耐药转运子基因的调查。
Malar J. 2013 Nov 19;12:426. doi: 10.1186/1475-2875-12-426.
9
Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.加纳恶性疟原虫分离株中 pfmdr1 基因拷贝数增加和 pfcrt 及 pfmdr1 耐药等位基因下降与抗疟药物治疗政策改变有关。
Malar J. 2013 Oct 30;12:377. doi: 10.1186/1475-2875-12-377.
10
Surveillance of artemether-lumefantrine associated Plasmodium falciparum multidrug resistance protein-1 gene polymorphisms in Tanzania.坦桑尼亚蒿甲醚-本芴醇相关恶性疟原虫多药耐药蛋白1基因多态性监测
Malar J. 2014 Jul 9;13:264. doi: 10.1186/1475-2875-13-264.

引用本文的文献

1
Artemisinin and partner drug resistance markers in Plasmodium falciparum from Tanzanian paediatric malaria patients, 2016-2022.2016 - 2022年坦桑尼亚儿童疟疾患者恶性疟原虫中青蒿素及联合用药耐药标志物
Malar J. 2025 Jul 1;24(1):209. doi: 10.1186/s12936-025-05447-x.
2
artemisinin partial resistance markers in Fort Portal, Western Uganda, 2024.2024年乌干达西部福特portal的青蒿素部分抗性标志物
Antimicrob Agents Chemother. 2025 Jun 4;69(6):e0175524. doi: 10.1128/aac.01755-24. Epub 2025 Apr 23.
3
Rapid and supersensitive allele detection of Plasmodium falciparum chloroquine resistance via a Pyrococcus furiosus argonaute-triggered dual-signal biosensing platform.通过 Pyrococcus furiosus 核酸酶触发的双重信号生物传感平台快速超灵敏检测恶性疟原虫氯喹耐药性的等位基因。
Parasit Vectors. 2024 Nov 24;17(1):488. doi: 10.1186/s13071-024-06575-0.
4
Polymorphisms in the Pfcrt, Pfmdr1, and Pfk13 genes of Plasmodium falciparum isolates from southern Brazzaville, Republic of Congo.来自刚果共和国布拉柴维尔南部的恶性疟原虫分离株中 Pfcrt、Pfmdr1 和 Pfk13 基因的多态性。
Sci Rep. 2024 Nov 14;14(1):27988. doi: 10.1038/s41598-024-78670-2.
5
Trend of N86Y and Y184F Mutations in Pfmdr1 Gene in Children Under Seasonal Malaria Chemoprevention Coverage in Nanoro, Burkina Faso.布基纳法索纳诺罗地区接受季节性疟疾化学预防的儿童中Pfmdr1基因N86Y和Y184F突变的趋势
Acta Parasitol. 2024 Dec;69(4):1967-1976. doi: 10.1007/s11686-024-00923-x. Epub 2024 Oct 2.
6
Exploring Genetic Silencing: RNAi and CRISPR-Cas Potential against Drug Resistance in Malaria.探索基因沉默:RNA干扰和CRISPR-Cas技术对抗疟疾耐药性的潜力
Mini Rev Med Chem. 2025;25(2):128-137. doi: 10.2174/0113895575306957240610102626.
7
Detection of Artemisinin Resistance Marker Kelch-13 469Y in Plasmodium falciparum, South Kivu, Democratic Republic of the Congo, 2022.2022 年在刚果民主共和国南基伍省检测到恶性疟原虫中的青蒿素耐药标记物 Kelch-13 469Y。
Am J Trop Med Hyg. 2024 Feb 20;110(4):653-655. doi: 10.4269/ajtmh.23-0740. Print 2024 Apr 3.
8
Escalating marker prevalence indicative of artemisinin resistance in southern Rwanda.卢旺达南部青蒿素耐药标志物流行率上升。
Antimicrob Agents Chemother. 2024 Jan 10;68(1):e0129923. doi: 10.1128/aac.01299-23. Epub 2023 Dec 11.
9
The structure of multidrug resistance protein 1 reveals an N-terminal regulatory domain.多药耐药蛋白 1 的结构揭示了一个 N 端调节结构域。
Proc Natl Acad Sci U S A. 2023 Aug 8;120(32):e2219905120. doi: 10.1073/pnas.2219905120. Epub 2023 Aug 1.
10
Dynamic changes in genetic diversity, drug resistance mutations, and treatment outcomes of falciparum malaria from the low-transmission to the pre-elimination phase on the islands of São Tomé and Príncipe.从低传播到即将消除阶段,圣多美和普林西比岛间日疟原虫的遗传多样性、耐药突变体和治疗结果的动态变化。
Malar J. 2021 Dec 14;20(1):467. doi: 10.1186/s12936-021-04007-3.

本文引用的文献

1
A molecular marker of artemisinin-resistant Plasmodium falciparum malaria.青蒿素耐药恶性疟原虫的一个分子标记。
Nature. 2014 Jan 2;505(7481):50-5. doi: 10.1038/nature12876. Epub 2013 Dec 18.
2
The role of Pfmdr1 and Pfcrt in changing chloroquine, amodiaquine, mefloquine and lumefantrine susceptibility in western-Kenya P. falciparum samples during 2008-2011.2008-2011 年期间,肯尼亚西部恶性疟原虫样本中 Pfmdr1 和 Pfcrt 对改变氯喹、阿莫地喹、甲氟喹和青蒿琥酯敏感性的作用。
PLoS One. 2013 May 13;8(5):e64299. doi: 10.1371/journal.pone.0064299. Print 2013.
3
Sulfadoxine-pyrimethamine resistance in Plasmodium falciparum: a zoomed image at the molecular level within a geographic context.疟原虫对磺胺多辛-乙胺嘧啶的耐药性:地理背景下分子水平的特写图像。
Acta Trop. 2013 Feb;125(2):163-90. doi: 10.1016/j.actatropica.2012.10.013. Epub 2012 Nov 3.
4
Molecular analysis of pfatp6 and pfmdr1 polymorphisms and their association with in vitro sensitivity in Plasmodium falciparum isolates from the Thai-Myanmar border.来自泰缅边境的恶性疟原虫分离株中 pfATP6 和 pfmdr1 多态性的分子分析及其与体外敏感性的关系。
Acta Trop. 2011 Oct-Nov;120(1-2):130-5. doi: 10.1016/j.actatropica.2011.07.003. Epub 2011 Jul 13.
5
Genomewide scan reveals amplification of mdr1 as a common denominator of resistance to mefloquine, lumefantrine, and artemisinin in Plasmodium chabaudi malaria parasites.全基因组扫描显示 mdr1 扩增是恶性疟原虫对甲氟喹、青蒿琥酯和青蒿素耐药的共同决定因素。
Antimicrob Agents Chemother. 2011 Oct;55(10):4858-65. doi: 10.1128/AAC.01748-10. Epub 2011 Jun 27.
6
Increased prevalence of the Plasmodium falciparum Pfmdr1 86N genotype among field isolates from Franceville, Gabon after replacement of chloroquine by artemether-lumefantrine and artesunate-mefloquine.在法国城市加蓬的班古替换氯喹为青蒿琥酯-咯萘啶和青蒿琥酯-甲氟喹后,恶性疟原虫 Pfmdr1 86N 基因型的流行率增加。
Infect Genet Evol. 2011 Mar;11(2):512-7. doi: 10.1016/j.meegid.2011.01.003. Epub 2011 Jan 17.
7
Molecular and physiologic basis of quinoline drug resistance in Plasmodium falciparum malaria.恶性疟原虫对喹啉类药物耐药性的分子与生理基础
Future Microbiol. 2009 May;4(4):441-55. doi: 10.2217/fmb.09.15.
8
A systematic review and meta-analysis of evidence for correlation between molecular markers of parasite resistance and treatment outcome in falciparum malaria.对恶性疟原虫抗寄生虫分子标志物与治疗结果之间相关性证据的系统评价和荟萃分析。
Malar J. 2009 May 4;8:89. doi: 10.1186/1475-2875-8-89.
9
Plasmodium falciparum pfmdr1 amplification, mefloquine resistance, and parasite fitness.恶性疟原虫pfmdr1基因扩增、甲氟喹耐药性与疟原虫适应性
Antimicrob Agents Chemother. 2009 Apr;53(4):1509-15. doi: 10.1128/AAC.00241-08. Epub 2009 Jan 21.
10
Chloroquine-resistance molecular markers (Pfcrt T76 and Pfmdr-1 Y86) and amodiaquine resistance in Burkina Faso.布基纳法索的氯喹抗性分子标记(Pfcrt T76和Pfmdr-1 Y86)及阿莫地喹抗性
Trop Med Int Health. 2008 Feb;13(2):238-40. doi: 10.1111/j.1365-3156.2007.01995.x.